Results 151 to 160 of about 191,476 (314)

FORMULATION OF AN ORAL CONTROLLED RELEASE DOSAGE FORM FOR NIFEDIPINE

, 1988
Varun Garg
openalex   +2 more sources

Surface Microbial Contamination in Some Commonly Available Tablet Dosage Forms [PDF]

, 2000
C.O. Obuekwe, Ifeyinwa Flossy Obuekwe, Maria Rafiq   +2 more
openalex   +1 more source

BCS1L‐Associated Disease: 5′‐UTR Variant Shifts the Phenotype Towards Axonal Neuropathy

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objectives To investigate the consequences of a pathogenic missense variant (c.838C>T; p.L280F) and a 5′‐UTR regulatory variant (c.‐122G>T) in BCS1L on disease pathogenesis and to understand how regulatory variants influence disease severity and clinical presentation.
Rotem Orbach, Nunziata Maio, Russell J. Butterfield, A. Reghan Foley, Sarah Silverstein, Yan Li, Katherine Chao, Tanya J. Lehky, Abigail Potticary, Tracey A. Rouault, Sandra Donkervoort, Carsten G. Bönnemann   +11 more
wiley   +1 more source

Updates on the conversion of nanosuspensions to solid oral dosage forms. [PDF]

J Food Drug Anal
Tsiaxerli A, Vardaka E, Moutroupidis C, Taylor KMG, Kachrimanis K, Malamatari M.   +5 more
europepmc   +1 more source

A Systematic Clinical Framework for Postimplantation Monitoring in Thalamic Neuromodulation: Insights From Twiddler's Syndrome

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT This case described a 25‐year‐old pregnant woman with refractory multifocal epilepsy, diagnosed in 2020 and treated with bilateral thalamic deep brain stimulation (DBS) targeting the centromedian and pulvinar nuclei. Prior to DBS, she experienced daily focal seizures, often progressing to generalized tonic–clonic seizures despite optimal ...
Shalin Shah, Ganne Chaitanya, Jeston Chin, Nicholas Delcimmuto, Jay R. Gavvala   +4 more
wiley   +1 more source

Bioavailability Enhancement and Formulation Technologies of Oral Mucosal Dosage Forms: A Review. [PDF]

Pharmaceutics
Bácskay I, Arany P, Fehér P, Józsa L, Vasvári G, Nemes D, Pető Á, Kósa D, Haimhoffer Á, Ujhelyi Z, Sinka D.   +10 more
europepmc   +1 more source

Inhalation Dosage Forms: A Focus on Dry Powder Inhalers and Their Advancements. [PDF]

Pharmaceuticals (Basel), 2023
Magramane S, Vlahović K, Gordon P, Kállai-Szabó N, Zelkó R, Antal I, Farkas D.   +6 more
europepmc   +1 more source

Gastro-intestinal absorption of ethyl 2-chloro-3-(4-(2-methyl-2-phenylpropyloxy)phenyl) propionate from different dosage forms in rats and dogs.

, 1990
Hajime Toguchi, Yutaka Ogawa, Katsumi Iga, Takatsuka Yashiki, Tsugio Shimamoto   +4 more
openalex   +2 more sources

Paroxysmal Dyskinesias Secondary to HHV‐6A Encephalitis: The First Case Report and Literature Review

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Paroxysmal dyskinesias encompasses a spectrum of conditions marked by intermittent involuntary movements, with paroxysmal kinesigenic dyskinesias being the most common phenotype. Central nervous system infection is a rare cause of paroxysmal dyskinesias.
Zhuoran Wang, Haiting Li, Xiaoping Du, Qiong Wang, Yating Zhang, Huifang Wang   +5 more
wiley   +1 more source

Automated 3D Printing-Based Non-Sterile Compounding Technology for Pediatric Corticosteroid Dosage Forms in a Health System Pharmacy Setting. [PDF]

Pharmaceutics
Bernhardt MB, Shokraneh F, Hrizanovska L, Lahtinen J, Brasher CA, Sandler N.   +5 more
europepmc   +1 more source